A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast Cancer
Journal of Breast Cancer · 2026 · 29 (2) · 141
DOI: 10.4048/jbc.2025.0256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Breast Cancer, 2026. Verfasst von Shinyoung Lee und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Asan Institute for Life Sciences, Asan Medical Center.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. drjiny@amc.seoul.kr.
ORCID-Profile: Shinyoung Lee, Hyehyun Jeong, Yeokyeong Shin, Jae Ho Jeong, Kyung Hae Jung, Sung-Bae Kim, Byung-Kwan Jeong, Hee Jin Lee, Gyungyub Gong, Hee Jung Shin, Hye Joung Eom, Young-Jin Lee, Tae-Kyung Yoo, Sae Byul Lee, Jisun Kim, Il-Yong Chung, Beom-Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Jin-Hee Ahn
Förderung
- Asan Institute for Life Sciences, Asan Medical Center
Zitieren
APA
Lee, S., Jeong, H., Shin, Y., Jeong, J. H., Jung, K. H., Kim, S. B., Jeong, B. K., Lee, H. J., Gong, G., Shin, H. J., Eom, H. J., Lee, Y. J., Yoo, T. K., Lee, S. B., Kim, J., Chung, I. Y., Ko, B. S., Kim, H. J., Lee, J. W., …, & Ahn, J. H. (2026). A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast Cancer. Journal of Breast Cancer, 29(2), 141. https://doi.org/10.4048/jbc.2025.0256
Vancouver
Lee S, Jeong H, Shin Y, Jeong JH, Jung KH, Kim SB, et al. A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast Cancer. Journal of Breast Cancer. 2026;29(2):141. doi:10.4048/jbc.2025.0256
BibTeX
@article{Lee2026,
author = {Lee, Shinyoung and Jeong, Hyehyun and Shin, Yeokyeong and Jeong, Jae Ho and Jung, Kyung Hae and Kim, Sung-Bae and Jeong, Byung-Kwan and Lee, Hee Jin and Gong, Gyungyub and Shin, Hee Jung and Eom, Hye Joung and Lee, Young-Jin and Yoo, Tae-Kyung and Lee, Sae Byul and Kim, Jisun and Chung, Il-Yong and Ko, Beom-Seok and Kim, Hee Jeong and Lee, Jong Won and Son, Byung Ho and Ahn, Jin-Hee},
title = {A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast Cancer},
journal = {Journal of Breast Cancer},
year = {2026},
volume = {29},
number = {2},
pages = {141},
doi = {10.4048/jbc.2025.0256}
}
EUVIMED